scispace - formally typeset
M

Michael Bamberg

Researcher at University of Tübingen

Publications -  411
Citations -  14528

Michael Bamberg is an academic researcher from University of Tübingen. The author has contributed to research in topics: Radiation therapy & Survival rate. The author has an hindex of 60, co-authored 409 publications receiving 13780 citations.

Papers
More filters
Journal ArticleDOI

NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide

TL;DR: IDH1 mutations are a novel positive prognostic factor in anaplastic gliomas, with a favorable impact stronger than that of 1p/19q codeletion or MGMT promoter methylation and associated with prolonged PFS in the chemotherapy and radiotherapy arm.
Journal ArticleDOI

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

Susanne Krege, +82 more
- 01 Mar 2008 - 
TL;DR: F refinements in the treatment of early- and advanced-stage testicular cancer have emerged from clinical trials, and expert clinical skills will continue to be one of the major determinants for the prognosis of patients with germ cell cancer.
Journal ArticleDOI

Cellular basis of radiation-induced fibrosis

TL;DR: The cellular mechanism of radiation-induced fibrosis can be seen as a multicellular process involving various interacting cell systems in the target organ resulting in the fibrotic phenotype of the fibroblast/fibrocyte cell system.